888 Holdings Plc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 888 holdings plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 888 Holdings Plc Today - Breaking & Trending Today

Stock Analysts' Updated EPS Estimates for December 4th (888, CPG, DS, EOSE, FDEV, FUTR, PTEC, PZC, SMDS, SYNC)

Stock Analysts’ updated eps estimates for Monday, December 4th: 888 (LON:888) had its hold rating reissued by analysts at Numis Securities Ltd. Compass Group (LON:CPG) had its buy rating reissued by analysts at Numis Securities Ltd. Drive Shack (LON:DS) was upgraded by analysts at Barclays PLC to an overweight rating. They currently have GBX 360 […] ....

Roth Mkm , Numis Securities Ltd , Citigroup Inc , Compass Group , Jefferies Financial Group Inc , Barclays Plc , Eos Energy Enterprises , Stock Analyst , Numis Securities , Jefferies Financial Group , 888 Holdings Plc , Compass Group Plc , Drive Shack Inc , Eos Energy Enterprises Inc , Frontier Developments Plc , Future Plc , Playtech Plc , Pz Cussons Plc , Ds Smith Plc ,

Reata Pharmaceuticals' (RETA) "Reiterates" Rating Reiterated at 888

Reata Pharmaceuticals (NASDAQ:RETA – Free Report)‘s stock had its “reiterates” rating reiterated by equities researchers at 888 in a research report issued on Wednesday, Benzinga reports. RETA has been the subject of a number of other reports. Stifel Nicolaus lifted their price objective on Reata Pharmaceuticals from $105.00 to $115.00 and gave the company a […] ....

United States , Manmeet Singh Soni , Stifel Nicolaus , Andrea Loewen , Emerald Mutual Fund Advisers , Reata Pharmaceuticals Inc , Reata Pharmaceuticals Stock , First Light Asset Management , Analyst Recommendations For Reata Pharmaceuticals , Emerald Advisers , Securities Exchange Commission , Reata Pharmaceuticals , News Ratings For Reata Pharmaceuticals Daily , Highmark Wealth Management , Free Report , Singh Soni , Exchange Commission , Mutual Fund Advisers Trust , Mark Wealth Management , Light Asset Management , Reata Pharmaceuticals Daily , Nasdaq Reta , Reiterated Rating , 888 Holdings Plc ,

California Water Service Group (NYSE:CWT) Receives Upgrade Rating from 888

California Water Service Group (NYSE:CWT – Free Report)‘s stock had its “upgrade” rating restated by 888 in a research report issued to clients and investors on Wednesday, Benzinga reports. Other equities research analysts have also issued reports about the company. Wells Fargo & Company upgraded California Water Service Group from an “underweight” rating to an […] ....

United States , New Mexico , Robertj Kuta , California Water Service Group , Managers Group , Insider Transactions At California Water Service Group , Humankind Investments , Wells Fargo Company , California Water Service Group Company Profile , California Water Service Group Stock Down , Securities Exchange Commission , Advisor Partners , Free Report , Water Service Group Stock Down , Water Service Group , California Water Service , Exchange Commission , Asset Management Gmbh , Captrust Financial Advisors , Financial Advisors , California Water Service Group Daily , Nyse Cwt , Reiterated Rating , 888 Holdings Plc ,

Reata Pharmaceuticals (NASDAQ:RETA) Stock Rating Reaffirmed by 888

Reata Pharmaceuticals (NASDAQ:RETA – Free Report)‘s stock had its “reiterates” rating reiterated by analysts at 888 in a research note issued to investors on Wednesday, Benzinga reports. A number of other equities analysts also recently weighed in on the stock. SVB Securities raised shares of Reata Pharmaceuticals from a “market perform” rating to an “outperform” […] ....

New Zealand General , New Zealand , Michaeld Wortley , Andrea Loewen , Wellington Management Group , Perceptive Advisors , Securities Exchange Commission , Analyst Recommendations For Reata Pharmaceuticals , News Ratings For Reata Pharmaceuticals Daily , Reata Pharmaceuticals Inc , Vanguard Group Inc , Hedge Funds Weigh In On Reata Pharmaceuticals , First Light Asset Management , Reata Pharmaceuticals , Blackrock Inc , Reata Pharmaceuticals Price Performance , Free Report , Exchange Commission , Management Group , Light Asset Management , Reata Pharmaceuticals Daily , Nasdaq Reta , Reiterated Rating , 888 Holdings Plc ,

Reata Pharmaceuticals (NASDAQ:RETA) Receives Reiterates Rating from 888

888 reiterated their reiterates rating on shares of Reata Pharmaceuticals (NASDAQ:RETA – Free Report) in a research report released on Wednesday, Benzinga reports. RETA has been the subject of several other research reports. LADENBURG THALM/SH SH raised their price objective on shares of Reata Pharmaceuticals from $104.00 to $122.00 in a research note on Thursday. […] ....

Robertw Baird , Manmeet Singh Soni , Andrea Loewen , Advisor Group Holdings Inc , Institutional Investors Weigh In On Reata Pharmaceuticals , China Universal Asset Management Co , Analyst Recommendations For Reata Pharmaceuticals , Reata Pharmaceuticals Inc , Reata Pharmaceuticals Stock Performance , Reata Pharmaceuticals Company Profile , International Assets Investment Management , Belpointe Asset Management , Us Bancorp , News Ratings For Reata Pharmaceuticals Daily , Reata Pharmaceuticals , Free Report , Moderate Buy , Singh Soni , Asset Management , Assets Investment Management , Universal Asset Management , Group Holdings , Reata Pharmaceuticals Daily , Nasdaq Reta , Reiterated Rating , 888 Holdings Plc ,